U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,409 records

Showing results for "analyzing".

  1. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  2. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    February 16, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  3. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…

  4. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

  5. Cannabis-Annual-Update2-Table-E1 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
    March 13, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  6. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  7. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  8. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  9. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  10. Appendix-E-Surveillance-Report-1 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1_0.xlsx
    November 22, 2021 - Title Appendix E - Study Characteristics NPP Author, Year Country Trial Name Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (weeks) Funding Source Placebo-controlled Hussain, 2021 Pakistan Fair NPP (DPN) Age, mean: …

  11. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

  12. Draft-Living-Review-Plant-Chronic-Pain-E-Evidence-Tables (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
    March 25, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  13. App-E-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

  14. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6) This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing

  15. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6) This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing

  16. Cover Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - of a web based drug effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis for analyzing … Previous Work Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use of information technology for large scale

  17. Cover Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
    September 01, 2007 - of a web based drug effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis for analyzing … Previous Work Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use of information technology for large scale

  18. S166 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s166.pdf
    October 01, 2007 - This method of analyzing indirect comparisons is sim- ple and straightforward and preserves the randomization … We combined these studies and the 3-arm trials (ie, trials analyzing BNZ, NBNZ, and placebo) included … In the current study, the indirect estimate included only 2-arm trials (ie, trials analyzing either BNZ … becomes particularly useful in this instance, as it yields a straightforward method of simultaneously analyzing

  19. Empirical and Simulation-Based Comparison of Univariate and Multivariate Meta-Analysis for Binary Outcomes | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/methods-binary-outcomes-evaluation/research
    March 20, 2013 - Empirical and Simulation-Based Comparison of Univariate and Multivariate Meta-Analysis for Binary Outcomes Research Report March 20, 2013 Web Version [NLM Site] Download Main Document PDF 7.9 MB People using assistive technology may not be able to fully access information in these files. For additional …

  20. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites